YOLFTbeta
30

Caina Technology Co. Ltd.

301122 · SHE · Healthcare / Medical Instruments & Supplies

53.90CNY-5.06 (-8.58%)

Price History

Full chart

Market Stats

Previous Close58.96
Open58.56
Day Range53.00 – 59.62
52-Week Range23.00 – 71.50
Volume5.47M
Market Cap8.15B
P/E (TTM)1333.40
Forward P/E0.00
EPS0.05
Dividend Yield0.06%
Beta0.87
50-Day Avg40.96
200-Day Avg32.54

About

Caina Technology Co., Ltd. engages in the research, development, production, and sale of plastic particles, needle holders, needle tubes, rubber plugs and other packaging materials. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. Caina Technology Co., Ltd. was founded in 2004 and is based in Jiangyin, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Jun Lu
  • Employees1.06K
  • HeadquartersNo. 253, Chenglu Road, Jiangyin, China, 214421, China
  • Websitehttps://www.caina.ltd

Leadership

  • Mr. Jun LuChairman & GM · b. 1971
  • Ms. Lingyun ZhaAccounting Supervisor, CFO & Director · b. 1972
  • Ms. Hong ZhaoDeputy GM & Director · b. 1974
  • Mr. Lijie ZhaoDeputy GM & Employee Representative Director · b. 1982
  • Mr. Weiwei LuBoard Secretary · b. 1994

Financials

Income Statement

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue93.02M143.38M181.31M505.01M442.05M465.49M410.47M387.89M356.69M
Growth (%)-+54.14%+26.46%+178.53%-12.47%+5.30%-11.82%-5.50%-8.04%
Cost of Revenue60.46M93.45M108.25M262.93M248.10M275.79M259.49M271.42M276.93M
Gross Profit32.56M49.93M73.06M242.08M193.95M189.69M150.98M116.48M79.76M
Gross Margin35.00%34.82%40.30%47.94%43.88%40.75%36.78%30.03%22.36%
Operating Expense19.89M28.08M32.41M79.23M42.09M9.82M21.49M59.01M76.54M
Operating Income12.67M21.85M40.65M162.84M151.86M179.87M129.50M57.46M3.22M
Operating Margin13.62%15.24%22.42%32.25%34.35%38.64%31.55%14.81%0.90%
EBITDA24.73M37.36M59.01M182.07M172.93M210.81M161.51M95.61M56.98M
EBITDA Margin26.59%26.06%32.55%36.05%39.12%45.29%39.35%24.65%15.97%
Net Income12.59M20.50M32.33M137.03M130.68M161.87M112.56M53.09M5.62M
Net Income Margin13.53%14.30%17.83%27.13%29.56%34.77%27.42%13.69%1.58%
R&D7.24M8.47M11.41M18.70M18.44M19.73M21.44M26.39M21.96M
R&D as % of Total Revenue7.79%5.91%6.29%3.70%4.17%4.24%5.22%6.80%6.16%
Interest Expense2.95M4.97M5.48M3.67M328.55K128.34K103.10K378.68K463.50K
Interest Expense % of Total Revenue3.17%3.47%3.02%0.73%0.07%0.03%0.03%0.10%0.13%

Balance Sheet

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets202.71M267.23M285.95M475.75M612.62M1.84B1.93B1.98B2.01B
Total Liabilities112.03M156.05M112.44M96.30M102.50M107.03M122.50M166.48M161.97M
Total Equity90.68M111.18M173.52M379.44M510.12M1.74B1.81B1.81B1.84B
Cash9.47M17.71M26.67M126.88M129.41M355.59M178.33M331.71M371.03M
Total Debt50.93M105.40M76.52M19.03M107.64K455.91K429.47K32.13M-
Net Debt41.46M87.69M49.84M-107.86M-129.30M-355.13M-177.90M-299.58M-

Cash Flow

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow407.95K21.33M57.71M170.02M160.05M138.88M87.05M105.44M18.66M
Investing Cash Flow-14.67M-47.93M-41.69M-50.12M-132.64M-991.91M-225.31M98.82M-
Financing Cash Flow1.46M34.35M-8.09M-15.66M-22.29M1.07B-42.88M-51.96M-
Capital Expenditure33.85M19.83M48.82M72.23M97.15M164.83M197.82M101.85M92.72M
Free Cash Flow-33.44M1.50M8.89M97.79M62.90M-25.95M-110.78M3.60M-74.07M
Dividends Paid2.89M4.85M5.49M23.73M264.23K32.91M42.32M48.90M30.56M
FCF to OCF-8196.65%7.05%15.40%57.52%39.30%-18.69%-127.26%3.41%-397.03%
Dividend Paid to FCF-8.64%322.32%61.73%24.27%0.42%-126.82%-38.20%1358.96%-41.26%

Earnings

Report DateApr 26, 2022Aug 24, 2022Oct 25, 2022Apr 27, 2023Aug 24, 2023Oct 29, 2023Apr 24, 2024Aug 27, 2024Oct 30, 2024Apr 24, 2025Aug 28, 2025Oct 25, 2025Apr 30, 2026Aug 26, 2026
EPS Estimate--------------
EPS Actual0.460.590.400.270.290.340.160.070.20-0.040.01-0.010.11-0.03
Surprise--------------
TimingPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-market----

Key Statistics & Ratios

Market Cap8.15B
Enterprise Value6.90B
Trailing P/E1333.40
Forward P/E0.00
Price / Sales17.30
Price / Book3.96
EPS0.05
Book Value15.48
Revenue (TTM)471.08M
Gross Profit (TTM)98.22M
EBITDA59.71M
Profit Margin1.30%
Operating Margin-6.52%
Return on Equity0.11%
Return on Assets-0.01%
Shares Outstanding122.25M
Shares Float32.00M
Beta0.87
Dividend Yield0.06%
Dividend Rate0.04
Payout Ratio55.79%

Dividends

20261×
0.04Jun 9, 2026
20251×
0.25May 30, 2025
20241×
0.40May 21, 2024
20231×
0.45May 16, 2023
20221×
0.27Apr 25, 2022

Stock Splits

  • May 16, 20231.3:1